3 Things We Might Hear From Illumina Next Week
Gene sequencing titan Illumina (NASDAQ: ILMN) usually uses its presentation at the J.P. Morgan Healthcare Conference to make its biggest product announcements of the year, and the company is scheduled to take the podium Monday, Jan. 13.
Three years ago, Illumina announced a new high-end sequencer, NovaSeq, and the stock jumped 17% in a day. As the company went on to execute a flawless product rollout, this growth stock had an incredible year, ending 2017 54% higher than the share price the day before the conference. More recently the stock has stagnated, currently trading 10% below its peak in September 2018.
What might we hear from Illumina at this year's conference, and could it provide a boost to the stock in 2020? Here are some educated guesses.
Source Fool.com
